Corporate Overview. March 2017

Size: px
Start display at page:

Download "Corporate Overview. March 2017"

Transcription

1 Corporate Overview March 2017

2 Bionano Genomics Overview Commercial-stage company developing and selling instruments & consumables for whole genome analysis Addressing the needs for: A better understanding of genome biology More actionable results from genome analyses Enabling researchers & clinicians to see large structural variations for biomarker discovery & clinical diagnosis Market sizes range from $5 billion to over $100 billion 2

3 Unlocking the Promise of Precision Medicine Requires Better Tools THE DRIVER OF THE GENOMICS MARKET WHAT WOULD UNLOCK GENOMICS POTENTIAL? THE KEY $5B market $110B market * Precision Medicine Closing of the Genome Analysis Gap Improving Our Understanding of Genome Biology Which Will Require Better Tools * Midpoint of JPMorgan s research & clinical market opportunity (ILMN report, May 2016). 3

4 Something s Missing In Genomics Today = What s missing? The ability to see all genome variants 4

5 The Gaps Are Evident In a patient population of presumptive genetic disease: 74% Undiagnosed 26% Diagnosed 74% of genetic disorders go undiagnosed with sequencing Dec. 2014; 312:

6 Bionano Sees the Variants that Sequencing Misses Bionano provides the longrange genomic information that reveals the missing genome variants 6

7 Bionano Delivers Unprecedented Long-Range Genomic Information at Throughput Comparable with Illumina Read Length Gb Per Run (Log Scale) Throughput Kbp 1 Mbp Length (Log Scale) 7

8 A Powerful Combination: Bionano NGM Sees What Illumina Misses NGS NGM Variation Type SNPs & Indels (<2kb) Variation Type SVs (>2kb) Size of Variant All SNPs, Indels & SVs Bionano Customer Presentation: This graph depicts the density of SVs found (y axis) relative to the size of the SV found (x axis) for NGM (solid lines) against NGS (dotted lines). For SVs greater than 2,000bp, NGS has very significant drop in detection. NGM s ability to see SVs picks up where NGS drops off. 8

9 Bionano NGM Sees Large SVs with Analytical Performance that Is Unbeatable Throughout Genomics Sensitivity 7.3x Improvement in Sensitivity for SVs over Illumina Insertions Deletions Homozygous 99.0% 75.6% Heterozygous 83.6% 43.0% Homozygous 99.6% 82.8% Heterozygous 92.3% 67.3% 1,570 SVs Found (>5kb) 215 Publication: biorxiv, Rapid Automated Large Structural Variation Detection in a Diploid Genome by Nanochannel Based Next-Generation Mapping, Publication: Genetics, UCSF,

10 Examples of How Bionano Is Making a Significant Impact Duchenne Muscular Dystrophy Eric Vilain, M.D., Ph. D. Prostate Cancer Vanessa Hayes, Ph.D. Seminal data presented at 2017 AGBT 11 presumed genetic disorder patients that had been on long diagnostic odysseys were included in the study Whole genome, arrays and multiplex PCR had all failed in providing a diagnosis Bionano revealed that 2 of the 11 patients had novel SVs that explained each patient s developmental phenotype 8 year-old boy: a deletion and 2 deep intronic mutations in MED17 gene 13 year-old girl: a deletion in EZH1 gene associated with skeletal development Dr. Vilain commented on the amazing prowess and clinical usefulness of Bionano s tool Groundbreaking results released in March 2017 Bionano was added to an NGS-driven prostate cancer study effort that had been searching for putative SVs for years Within the first few patients tested, Bionano found hundreds of potentially important SVs (90% of which were missed by Illumina) Importantly, compared to Illumina, SVs called by Bionano had a 100x greater likelihood of impacting a putative oncogene Dr. Hayes now seeking to open the first-in-the-world Cancer Genome Mapping Facility based around the Bionano Genomics technology 10

11 Digital Solution for Karyotyping and FISH Example: Bionano can replace dual method (karyotyping & FISH) for finding the 8 lesions of AML Karyotyping Bionano DISEASE SVs DUAL METHOD TEST AML del(5q) inv(3) inv (16) t(8,21) t(15,17) t(9,11) t(6,9) t(1,22) Chromosome analysis (Karyotyping) + Fluorescence In Situ Hybridization (FISH) FISH Systematic SV detection to simplify hematological malignancy detection 11

12 Clinical Partnership in China with Berry Genomics to Create Digital Cytogenetic Products Genetic Disorders and Cancer Develop Submit Market Bionano and Berry will provide CFDA-approved alternatives to karyotyping, FISH and microarrays in reproductive health, inherited diseases and oncology in China and pave the way for U.S. FDA-cleared systems 12

13 Most Recent Accomplishments 60th Strategic alliance established VGP announces thousands of vertebrate genomes to be run on Bionano Bionano instrument installed Publication of Bionano s >90% SV sensitivity vs. PacBio s 54% Global product launch Aug 2016 Sep 2016 Oct 2016 Nov 2016 Dec 2016 Jan 2017 Feb 2017 Mar 2017 Former Illumina CSO becomes Bionano Chairman First purchase of next-generation beta instrument by Berry $7M Record annual revenues achieved UCLA presents putative SVs found in undiagnosed children Garvan publishes 10x more SVs found versus NGS in prostate cancer 13

14 Bionano s Installed Base Includes Leading Academic and Industrial Genome Researchers Around the World EXAMPLES OF USERS 68 Bionano systems adopted 14

15 Bionano s Key Technology: Nanochannels Bionano s chips are fabricated from standard semiconductor silicon wafers A Bionano chip contains up to 150,000 nanochannels, each 50 nanometers wide DNA is deposited into the well of the chip and moved into the nanochannels via electrophoresis As the DNA passes into the nanochannel, it linearizes and is then imaged 15

16 Bionano Workflow 16

17 Bionano Genomics Overview Commercial-stage company developing and selling instruments & consumables for whole genome analysis Addressing the needs for: A better understanding of genome biology More actionable results from genome analyses Enabling researchers & clinicians to see large structural variations for biomarker discovery & clinical diagnosis Market sizes range from $5 billion to over $100 billion 17

18 Appendix 18

19 Mapping Was a Foundational Concept Limited By Throughput & Cost Until Now FISH RFLP BAC YAC acgh 70 s-90 s Genome Mapping 2000 s Shotgun Sequencing & SBS Next-Generation Mapping RFLP, FISH, BAC, YAC, acgh Mapping + Nanotechnology NGS, SNPs, Genes Optical Mapping + Nanotechnology 2013 Launch /3 Human/Day Human/Day Humans/Day 19

20 Genome Complexity Is the Issue 55% of human genome is repeats 55% repeats Repeats hide the order & orientation of functional elements of the genome, including genes NGS spans only 5% of repeats 5% NGS misses the Structural Variations (SVs) that drive biology and pathology Illumina primarily provides SNP & small SV detection. Going beyond requires long-range information 20

21 A Mosaic of Technologies Is Needed to Succeed NGS SNPs Small SVs Mapping Small to Long SVs CNVs Bionano Mapping Is Being Readily Added to the Mosaic Because of Its: Arrays Gene Expression Synthetic Reads Additional Small SVs Long Read Sequencing Small to Medium SVs Proven utility Straight forward adoption Ease of use Low cost per genome 21

22 SNP Detection Alone Is Not Enough: SVs Need to Be Seen Which Requires Additional Technology SNPs: Biology of Therapeutic Response SVs: Biology of Disease 22

23 Comprehensive Genome Assembly Bionano Complements All Three NGS Approaches APPROACH 1 APPROACH 2 APPROACH 3 NGS NGM Unprecedented levels of completion for human and non-human genome assemblies Eliminates need for laborious, time-consuming and extremely costly clone methods (BAC, YAC, etc) Essential for creating gold standards for biomarker discovery and for building reference genomes for non-model organisms Bionano is the essential component for achieving these results 23

24 Bionano Selected By Dr. Erich Jarvis to Be an Anchor Technology for 66,000 Vertebrate Genome References 24

25 Management Erik Holmlin, PhD President & Chief Executive Officer Han Cao, PhD Founder & Chief Scientific Officer Mike Ward Chief Business Officer Mark Borodkin VP Systems Development Sean Paolino VP Finance Domain Associates Exiqon BD GeneOhm Applied Proteomics Xagenic Dupont Princeton U Penn Peking Univ USTC Credit Suisse Wasserstein Leerink Partners Brooks Life Science Affymetrix Siemens Healthcare Life Technologies Life Technologies Applied Biosystems 25

26 Board and Scientific Advisors David Barker, PhD Chairman; Independent Director Former CSO Illumina Darren Cai, PhD Legend Capital Brian Halak, PhD Domain Associates Albert Luderer, PhD Independent Director CEO Integrated Dx Pui-Yan Kwok, M.D., Ph.D. Henry Bachrach Distinguished Professor, University of California, San Francisco Charles Lee, Ph.D. Director, The Jackson Laboratory for Genomic Medicine Co-chair of the Structural Genomic Variation Analysis group for the 1000 Genomes Project ( 26

27 Historical and Projected Financials In million of U.S. dollars 27

28 Thank You! Contact: Erik Holmlin, Ph.D., CEO 28

Corporate Overview of BioNano Genomics, Inc. September 2016

Corporate Overview of BioNano Genomics, Inc. September 2016 Corporate Overview of BioNano Genomics, Inc. September 2016 BioNano Is the Key to Unlocking the $100+ Billion Potential of the Genomics Market Market Size Growth Catalyst Key Driver Bottleneck $40B- $110B

More information

Corporate Overview. December Erik Holmlin President & CEO

Corporate Overview. December Erik Holmlin President & CEO Corporate Overview December 2018 Erik Holmlin President & CEO Forward-Looking Statements This presentation contains forward-looking statements. Forward-looking statements describe future expectations,

More information

Bionano Genomics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2018

Bionano Genomics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2018 Bionano Genomics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2018 Highlights: Record quarterly revenue of $4.0 million; 41% increase over 4Q17 Record annual revenue of

More information

to precision medicine

to precision medicine QIAGEN at the AMP 2018 Annual Meeting yourpath Discover to precision medicine Sample to Insight Discover your path to precision medicine Lead the way with QIAGEN, from Sample to Insight Every day, data

More information

SEQUENCING. M Ataei, PhD. Feb 2016

SEQUENCING. M Ataei, PhD. Feb 2016 CLINICAL NEXT GENERATION SEQUENCING M Ataei, PhD Tehran Medical Genetics Laboratory Feb 2016 Overview 2 Background NGS in non-invasive prenatal diagnosis (NIPD) 3 Background Background 4 In the 1970s,

More information

Jefferies Healthcare Conference. Frank Witney, President & CEO

Jefferies Healthcare Conference. Frank Witney, President & CEO Jefferies Healthcare Conference Frank Witney, President & CEO Forward Looking Statement This presentation contains statements that are "forward-looking statements" within the meaning of the Securities

More information

An innovative approach to genetic testing for improved patient care

An innovative approach to genetic testing for improved patient care An innovative approach to genetic testing for improved patient care Blueprint Genetics Blueprint Genetics is changing diagnostics by providing fast, affordable and comprehensive genetic knowledge Who we

More information

Introduction to Bioinformatics

Introduction to Bioinformatics Introduction to Bioinformatics Richard Corbett Canada s Michael Smith Genome Sciences Centre Vancouver, British Columbia June 28, 2017 Our mandate is to advance knowledge about cancer and other diseases

More information

Structural variation. Marta Puig Institut de Biotecnologia i Biomedicina Universitat Autònoma de Barcelona

Structural variation. Marta Puig Institut de Biotecnologia i Biomedicina Universitat Autònoma de Barcelona Structural variation Marta Puig Institut de Biotecnologia i Biomedicina Universitat Autònoma de Barcelona Genetic variation How much genetic variation is there between individuals? What type of variants

More information

Targeted Sequencing in the NBS Laboratory

Targeted Sequencing in the NBS Laboratory Targeted Sequencing in the NBS Laboratory Christopher Greene, PhD Newborn Screening and Molecular Biology Branch Division of Laboratory Sciences Gene Sequencing in Public Health Newborn Screening February

More information

NUCLEOTIDE RESOLUTION STRUCTURAL VARIATION DETECTION USING NEXT- GENERATION WHOLE GENOME RESEQUENCING

NUCLEOTIDE RESOLUTION STRUCTURAL VARIATION DETECTION USING NEXT- GENERATION WHOLE GENOME RESEQUENCING NUCLEOTIDE RESOLUTION STRUCTURAL VARIATION DETECTION USING NEXT- GENERATION WHOLE GENOME RESEQUENCING Ken Chen, Ph.D. kchen@genome.wustl.edu The Genome Center, Washington University in St. Louis The path

More information

The Diploid Genome Sequence of an Individual Human

The Diploid Genome Sequence of an Individual Human The Diploid Genome Sequence of an Individual Human Maido Remm Journal Club 12.02.2008 Outline Background (history, assembling strategies) Who was sequenced in previous projects Genome variations in J.

More information

The Irys System. Rapid Genome Wide Mapping for de novo Assembly and Structural Variation Analysis. Jack Peart, Ph.D. Director of Sales EMEA

The Irys System. Rapid Genome Wide Mapping for de novo Assembly and Structural Variation Analysis. Jack Peart, Ph.D. Director of Sales EMEA The Irys System Rapid Genome Wide Mapping for de novo Assembly and Structural Variation Analysis Jack Peart, Ph.D. Director of Sales EMEA BioNano Snapshot Developed & Commercialized the Irys System for

More information

Single Cell Genomics (SCG): Market Size, Segmentation, Growth, Competition and Trends ( )

Single Cell Genomics (SCG): Market Size, Segmentation, Growth, Competition and Trends ( ) Single Cell Genomics (SCG): Market Size, Segmentation, Growth, Competition and Trends (2013-2021) May, 2017 3 rd Edition Information contained in this market report is believed to be reliable at the time

More information

Human Genomics, Precision Medicine, and Advancing Human Health. The Human Genome. The Origin of Genomics : 1987

Human Genomics, Precision Medicine, and Advancing Human Health. The Human Genome. The Origin of Genomics : 1987 Human Genomics, Precision Medicine, and Advancing Human Health Eric Green, M.D., Ph.D. Director, NHGRI The Human Genome Cells Nucleus Chromosome DNA Human Genome: 3 Billion Bases (letters) The Origin of

More information

Megan Schmidt Vice President of Product Management, CompuGroup Medical

Megan Schmidt Vice President of Product Management, CompuGroup Medical Thursday April 6, 2017 A01 Molecular and Genetic Testing: How to Position your Laboratory for New Technology Megan Schmidt Vice President of Product Management, CompuGroup Medical DESCRIPTION: Molecular

More information

Lecture #1. Introduction to microarray technology

Lecture #1. Introduction to microarray technology Lecture #1 Introduction to microarray technology Outline General purpose Microarray assay concept Basic microarray experimental process cdna/two channel arrays Oligonucleotide arrays Exon arrays Comparing

More information

QIAGEN s NGS Solutions for Biomarkers NGS & Bioinformatics team QIAGEN (Suzhou) Translational Medicine Co.,Ltd

QIAGEN s NGS Solutions for Biomarkers NGS & Bioinformatics team QIAGEN (Suzhou) Translational Medicine Co.,Ltd QIAGEN s NGS Solutions for Biomarkers NGS & Bioinformatics team QIAGEN (Suzhou) Translational Medicine Co.,Ltd 1 Our current NGS & Bioinformatics Platform 2 Our NGS workflow and applications 3 QIAGEN s

More information

DNA Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast,

DNA Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, DNA Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013-2019 The completion of human genome project resulted in discovery of several human disease causing genes.

More information

Exome Sequencing Exome sequencing is a technique that is used to examine all of the protein-coding regions of the genome.

Exome Sequencing Exome sequencing is a technique that is used to examine all of the protein-coding regions of the genome. Glossary of Terms Genetics is a term that refers to the study of genes and their role in inheritance the way certain traits are passed down from one generation to another. Genomics is the study of all

More information

Invitae Corporation (Exact name of registrant as specified in its charter)

Invitae Corporation (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: March 12, 2018 (Date

More information

Genomics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research

Genomics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research Genomics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research " Increasing usage of novel genomics techniques and tools, evaluation of their benefit to patient outcome and focusing

More information

BD Strategy Overview. Advancing the world of health. Vincent A. Forlenza Chairman, Chief Executive Officer and President

BD Strategy Overview. Advancing the world of health. Vincent A. Forlenza Chairman, Chief Executive Officer and President BD Strategy Overview Advancing the world of health Vincent A. Forlenza Chairman, Chief Executive Officer and President BD IS AT THE VERY BEGINNING OF AN AMAZING JOURNEY WHERE WE CAN HAVE A PROFOUND IMPACT

More information

The Expanded Illumina Sequencing Portfolio New Sample Prep Solutions and Workflow

The Expanded Illumina Sequencing Portfolio New Sample Prep Solutions and Workflow The Expanded Illumina Sequencing Portfolio New Sample Prep Solutions and Workflow Marcus Hausch, Ph.D. 2010 Illumina, Inc. All rights reserved. Illumina, illuminadx, Solexa, Making Sense Out of Life, Oligator,

More information

Introducing combined CGH and SNP arrays for cancer characterisation and a unique next-generation sequencing service. Dr. Ruth Burton Product Manager

Introducing combined CGH and SNP arrays for cancer characterisation and a unique next-generation sequencing service. Dr. Ruth Burton Product Manager Introducing combined CGH and SNP arrays for cancer characterisation and a unique next-generation sequencing service Dr. Ruth Burton Product Manager Today s agenda Introduction CytoSure arrays and analysis

More information

Outline General NGS background and terms 11/14/2016 CONFLICT OF INTEREST. HLA region targeted enrichment. NGS library preparation methodologies

Outline General NGS background and terms 11/14/2016 CONFLICT OF INTEREST. HLA region targeted enrichment. NGS library preparation methodologies Eric T. Weimer, PhD, D(ABMLI) Assistant Professor, Pathology & Laboratory Medicine, UNC School of Medicine Director, Molecular Immunology Associate Director, Clinical Flow Cytometry, HLA, and Immunology

More information

Fundamentals of Next-Generation Sequencing: Technologies and Applications

Fundamentals of Next-Generation Sequencing: Technologies and Applications Fundamentals of Next-Generation Sequencing: Technologies and Applications Society for Hematopathology European Association for Haematopathology 2017 Workshop Eric Duncavage, MD Washington University in

More information

Complementary Technologies for Precision Genetic Analysis

Complementary Technologies for Precision Genetic Analysis Complementary NGS, CGH and Workflow Featured Publication Zhu, J. et al. Duplication of C7orf58, WNT16 and FAM3C in an obese female with a t(7;22)(q32.1;q11.2) chromosomal translocation and clinical features

More information

Whole genome sequencing in the UK Biobank

Whole genome sequencing in the UK Biobank Whole genome sequencing in the UK Biobank Part of the UK Government s Industrial Strategy Challenge Fund (ISCF) for the Data to Early Diagnosis and Precision Medicine initiative Aim to produce deep characterisation

More information

Welcome to the NGS webinar series

Welcome to the NGS webinar series Welcome to the NGS webinar series Webinar 1 NGS: Introduction to technology, and applications NGS Technology Webinar 2 Targeted NGS for Cancer Research NGS in cancer Webinar 3 NGS: Data analysis for genetic

More information

FREQUENTLY ASKED QUESTIONS

FREQUENTLY ASKED QUESTIONS FREQUENTLY ASKED QUESTIONS Q: WHAT IS HUMAN LONGEVITY INC.? A: Human Longevity, Inc. (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.

More information

The New Genome Analyzer IIx Delivering more data, faster, and easier than ever before. Jeremy Preston, PhD Marketing Manager, Sequencing

The New Genome Analyzer IIx Delivering more data, faster, and easier than ever before. Jeremy Preston, PhD Marketing Manager, Sequencing The New Genome Analyzer IIx Delivering more data, faster, and easier than ever before Jeremy Preston, PhD Marketing Manager, Sequencing Illumina Genome Analyzer: a Paradigm Shift 2000x gain in efficiency

More information

The 100,000 Genomes Project

The 100,000 Genomes Project The 100,000 Genomes Project Dr Tom Fowler, Deputy Chief Scientist Genomics England Jillian Hastings Ward, Chair, National 100K Participant Panel The Kings Fund, 6th October 2017 Our Mission 100,000 whole

More information

DNA. bioinformatics. genomics. personalized. variation NGS. trio. custom. assembly gene. tumor-normal. de novo. structural variation indel.

DNA. bioinformatics. genomics. personalized. variation NGS. trio. custom. assembly gene. tumor-normal. de novo. structural variation indel. DNA Sequencing T TM variation DNA amplicon mendelian trio genomics NGS bioinformatics tumor-normal custom SNP resequencing target validation de novo prediction personalized comparative genomics exome private

More information

Understanding the science and technology of whole genome sequencing

Understanding the science and technology of whole genome sequencing Understanding the science and technology of whole genome sequencing Dag Undlien Department of Medical Genetics Oslo University Hospital University of Oslo and The Norwegian Sequencing Centre d.e.undlien@medisin.uio.no

More information

Molecular Pathology Coding Workgroup Fly-In

Molecular Pathology Coding Workgroup Fly-In Molecular Pathology Coding Workgroup Fly-In What CPT Is Role of Current Procedural Terminology Nomenclature: Coding CPT is a listing of descriptive terms and identifying codes for reporting medical services

More information

Personalized Human Genome Sequencing

Personalized Human Genome Sequencing Personalized Human Genome Sequencing Dr. Stefan Platz DABT, Global Head Drug Safety & Metabolism Biomedical research: strengths & limitations of non-animal alternatives 06 December 2016 The Human Genome

More information

Centre for NanoHealth

Centre for NanoHealth Steve Conlan PhD An integrated collaborative base for businesses in Wales Director - Reproductive Biology & Cancer Research Institute of Life Science School of Medicine Unique interdisciplinary R&D environment,

More information

Biotechnology Chapter 20

Biotechnology Chapter 20 Biotechnology Chapter 20 DNA Cloning DNA Cloning AKA Plasmid-based transformation or molecular cloning First off-let s sum up what happens. A plasmid is taken from a bacteria A gene is inserted into the

More information

Innovations in Molecular Lab Operation. Joseph M. Campos, PhD, D(ABMM), F(AAM)

Innovations in Molecular Lab Operation. Joseph M. Campos, PhD, D(ABMM), F(AAM) Innovations in Molecular Lab Operation Lessons in the Best Ways to Blend Automation, Lean Workflow, and Paperless Processes Joseph M. Campos, PhD, D(ABMM), F(AAM) Interim Chief, Division of Laboratory

More information

Target Enrichment Strategies for Next Generation Sequencing

Target Enrichment Strategies for Next Generation Sequencing Target Enrichment Strategies for Next Generation Sequencing Anuj Gupta, PhD Agilent Technologies, New Delhi Genotypic Conference, Sept 2014 NGS Timeline Information burst Nearly 30,000 human genomes sequenced

More information

Genomes contain all of the information needed for an organism to grow and survive.

Genomes contain all of the information needed for an organism to grow and survive. Section 3: Genomes contain all of the information needed for an organism to grow and survive. K What I Know W What I Want to Find Out L What I Learned Essential Questions What are the components of the

More information

Total genomic solutions for biobanks. Maximizing the value of your specimens.

Total genomic solutions for biobanks. Maximizing the value of your specimens. Total genomic solutions for biobanks. Maximizing the value of your specimens. Unlock the true potential of your biological samples. Greater understanding. Increased value. Value-driven biobanking. Now

More information

TRANSFORMING GLOBAL GENETIC DATA INTO MEDICAL DECISIONS

TRANSFORMING GLOBAL GENETIC DATA INTO MEDICAL DECISIONS TRANSFORMING GLOBAL GENETIC DATA INTO MEDICAL DECISIONS THE DOORS ARE OPEN: FEEL FREE TO COME IN CENTOGENE UNLOCKS THE POWER OF GENETIC INSIGHTS TO IMPROVE THE QUALITY OF LIFE OF PATIENTS WITH GENETIC

More information

Agilent NGS Solutions : Addressing Today s Challenges

Agilent NGS Solutions : Addressing Today s Challenges Agilent NGS Solutions : Addressing Today s Challenges Charmian Cher, Ph.D Director, Global Marketing Programs 1 10 years of Next-Gen Sequencing 2003 Completion of the Human Genome Project 2004 Pyrosequencing

More information

Outline. Impact on Human Diseases Basis for Molecular Assay Novel Biomarkers

Outline. Impact on Human Diseases Basis for Molecular Assay Novel Biomarkers MOLECULAR DIAGNOSITICS 1 Outline Concept of Molecular Diagnostics History of Molecular Diagnostics Impact on Human Diseases Basis for Molecular Assay Novel Biomarkers 2 Molecular Diagnosis Molecular diagnosis

More information

Genomic solutions for complex disease

Genomic solutions for complex disease Genomic solutions for complex disease Power your with our genomic solutions Access a breadth of applications. Gain a depth of insights. To enhance their understanding of complex disease, researchers are

More information

HaloPlex HS. Get to Know Your DNA. Every Single Fragment. Kevin Poon, Ph.D.

HaloPlex HS. Get to Know Your DNA. Every Single Fragment. Kevin Poon, Ph.D. HaloPlex HS Get to Know Your DNA. Every Single Fragment. Kevin Poon, Ph.D. Sr. Global Product Manager Diagnostics & Genomics Group Agilent Technologies For Research Use Only. Not for Use in Diagnostic

More information

Konica Minolta to Acquire Invicro (US)

Konica Minolta to Acquire Invicro (US) Konica Minolta to Acquire Invicro (US) Acceleration of expansion of precision medicine business Offering new value for drug discovery and development in immuno-oncology and neurodegenerative disease September

More information

Design a super panel for comprehensive genetic testing

Design a super panel for comprehensive genetic testing Design a super panel for comprehensive genetic testing Rong Chen, Ph.D. Assistant Professor Director of Clinical Genome Sequencing Dept. of Genetics and Genomic Sciences Institute for Genomics and Multiscale

More information

Konica Minolta and INCJ Agree to Acquire Ambry Genetics in a Deal Valued at US$1 billion

Konica Minolta and INCJ Agree to Acquire Ambry Genetics in a Deal Valued at US$1 billion News Release Konica Minolta and INCJ Agree to Acquire Ambry Genetics in a Deal Valued at US$1 billion Advances Konica Minolta strategy to establish a leadership position in precision medicine Contributes

More information

American Board of Medical Genetics and Genomics

American Board of Medical Genetics and Genomics American Board of Medical Genetics and Genomics Logbook Guidelines for Certification in Laboratory Genetics and Genomics for the 2019 Examination as of 11/10/2016 Purpose: The purpose of the logbook is

More information

Sample to Insight. Dr. Bhagyashree S. Birla NGS Field Application Scientist

Sample to Insight. Dr. Bhagyashree S. Birla NGS Field Application Scientist Dr. Bhagyashree S. Birla NGS Field Application Scientist bhagyashree.birla@qiagen.com NGS spans a broad range of applications DNA Applications Human ID Liquid biopsy Biomarker discovery Inherited and somatic

More information

Performance of the Newly Developed Non-Invasive Prenatal Multi- Gene Sequencing Screen

Performance of the Newly Developed Non-Invasive Prenatal Multi- Gene Sequencing Screen 1 // Performance of the Newly Developed Non-Invasive Prenatal Multi- Gene Sequencing Screen ABSTRACT Here we describe the analytical performance of the newly developed non-invasive prenatal multi-gene

More information

Delivering on the Promise of Precision Medicine

Delivering on the Promise of Precision Medicine Delivering on the Promise of Precision Medicine Bay Area Council Economic Institute Spring 2016 The Promise of Precision Medicine The Bay Area is one of the world s biggest hubs for innovation in research

More information

Employment in the biopharma industry grew almost 5 percent in 2014, the last full year for which we have data. This is the highest annual growth rate

Employment in the biopharma industry grew almost 5 percent in 2014, the last full year for which we have data. This is the highest annual growth rate Thank you, Mr. Chairman, and members of the committee. I m Sarah MacDonald, Executive Vice President at MassBio, the life sciences trade association now representing over 700 member organizations. First,

More information

Titelstijl van model bewerken

Titelstijl van model bewerken Generate Titelstijl van and verify model your bewerken data Solutions for all your genetic analysis needs Sanger Sequencing Microarray technology QuantStudio real-time and digital PCR Ion Torrent NGS systems

More information

GENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE)

GENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE) TriMark Publications April 2007 Volume: TMRGER07-0401 GENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE) Trends, Industry Participants, Product Overviews and Market Drivers TABLE OF CONTENTS

More information

The Human Genome and its upcoming Dynamics

The Human Genome and its upcoming Dynamics The Human Genome and its upcoming Dynamics Matthias Platzer Genome Analysis Leibniz Institute for Age Research - Fritz-Lipmann Institute (FLI) Sequencing of the Human Genome Publications 2004 2001 2001

More information

Powering the Synthetic Biology and Genomics Revolutions

Powering the Synthetic Biology and Genomics Revolutions Powering the Synthetic Biology and Genomics Revolutions Advances in Genome Biology and Technology Marco Island, Florida February 28, 2019 Safe Harbor Statement This presentation contains forward-looking

More information

Cancer Genetics Solutions

Cancer Genetics Solutions Cancer Genetics Solutions Cancer Genetics Solutions Pushing the Boundaries in Cancer Genetics Cancer is a formidable foe that presents significant challenges. The complexity of this disease can be daunting

More information

Illumina Genome Analyzer. Progenika Experience. - Susana Catarino -

Illumina Genome Analyzer. Progenika Experience. - Susana Catarino - Illumina Genome Analyzer Progenika Experience - Susana Catarino - Who are we? 2000 PROGENIKA BIOPHARMA Development, production and commercialization of new genomic tools for diagnosis, prognosis and drug-response

More information

FDA Regulation of Companion Diagnostics

FDA Regulation of Companion Diagnostics FDA Regulation of Companion Diagnostics Paul Radensky October 11, 2017 Disclosure + Slideset drawn from Part I of presentation made by Janice Hogan, HoganLovells, October 2016 + Updated where appropriate

More information

Detecting Structural Variants in PacBio Reads Tools and Applications

Detecting Structural Variants in PacBio Reads Tools and Applications Detecting Structural Variants in PacBio Reads Tools and Applications Aaron Wenger 2017-06-28 For Research Use Only. Not for use in diagnostics procedures. Copyright 2017 by Pacific Biosciences of California,

More information

NGS-based innovations within the Leiden Network

NGS-based innovations within the Leiden Network NGS-based innovations within the Leiden Network A strong bridge between two partners Dr. Mark de Jong 2017-09-29 Design accurate and robust NGS tests and generate data sets essential for Diagnostics &

More information

3. human genomics clone genes associated with genetic disorders. 4. many projects generate ordered clones that cover genome

3. human genomics clone genes associated with genetic disorders. 4. many projects generate ordered clones that cover genome Lectures 30 and 31 Genome analysis I. Genome analysis A. two general areas 1. structural 2. functional B. genome projects a status report 1. 1 st sequenced: several viral genomes 2. mitochondria and chloroplasts

More information

Certification in Laboratory Genetics and Genomics Logbook Guidelines 2019 Examination

Certification in Laboratory Genetics and Genomics Logbook Guidelines 2019 Examination Certification in Laboratory Genetics and Genomics Logbook Guidelines 2019 Examination Purpose: The purpose of the logbook is to document that the applicant has had direct and meaningful involvement in

More information

E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research

E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research www.hcltech.com E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research whitepaper April 2015 TABLE OF CONTENTS Introduction 3 Challenges associated with NGS data analysis 3 HCL s NGS Solution

More information

resequencing storage SNP ncrna metagenomics private trio de novo exome ncrna RNA DNA bioinformatics RNA-seq comparative genomics

resequencing storage SNP ncrna metagenomics private trio de novo exome ncrna RNA DNA bioinformatics RNA-seq comparative genomics RNA Sequencing T TM variation genetics validation SNP ncrna metagenomics private trio de novo exome mendelian ChIP-seq RNA DNA bioinformatics custom target high-throughput resequencing storage ncrna comparative

More information

INTRODUCTION NEW GENETIC TECHNIQUES IN METABOLIC DISEASES 26/01/2016 FROM ONE GENERATION TO THE NEXT. Image challenge of the week D.

INTRODUCTION NEW GENETIC TECHNIQUES IN METABOLIC DISEASES 26/01/2016 FROM ONE GENERATION TO THE NEXT. Image challenge of the week D. NEW GENETIC TECHNIQUES IN METABOLIC DISEASES D. RYMEN, MD, PHD Pentalfa session Leuven, January 21 st 2016 INTRODUCTION Image challenge of the week 1 INTRODUCTION But what about Hypotonia Facial dysmorphism

More information

Satellite Education Workshop (SW4): Epigenomics: Design, Implementation and Analysis for RNA-seq and Methyl-seq Experiments

Satellite Education Workshop (SW4): Epigenomics: Design, Implementation and Analysis for RNA-seq and Methyl-seq Experiments Satellite Education Workshop (SW4): Epigenomics: Design, Implementation and Analysis for RNA-seq and Methyl-seq Experiments Saturday March 17, 2012 Orlando, Florida Workshop Description: This full day

More information

Informed Consent for Columbia Combined Genetic Panel (CCGP) for Adults Please read the following

Informed Consent for Columbia Combined Genetic Panel (CCGP) for Adults Please read the following Informed Consent for Columbia Combined Genetic Panel (CCGP) for Adults Please read the following form carefully and discuss with your ordering physician/genetic counselor before signing consent. 1. The

More information

AIT - Austrian Institute of Technology

AIT - Austrian Institute of Technology BIOMARKER DISCOVERY, BIOINFORMATICS, AND BIOSENSOR DEVELOPMENT Technology Experience AIT Austrian Institute of Technology Low-Emission Transport AIT - Austrian Institute of Technology Energy Health & Bioresources

More information

Chapter 5. Structural Genomics

Chapter 5. Structural Genomics Chapter 5. Structural Genomics Contents 5. Structural Genomics 5.1. DNA Sequencing Strategies 5.1.1. Map-based Strategies 5.1.2. Whole Genome Shotgun Sequencing 5.2. Genome Annotation 5.2.1. Using Bioinformatic

More information

Preanalytical Variables in Blood Collection: Impact on Precision Medicine

Preanalytical Variables in Blood Collection: Impact on Precision Medicine Preanalytical Variables in Blood Collection: Impact on Precision Medicine Carolyn Compton, MD, PhD Chair, Scientific Advisory Committee, Indivumed GmbH Professor of Life Sciences, ASU Professor of Laboratory

More information

Long-range gene regulation

Long-range gene regulation Long-range gene regulation Short Course in Medical Genetics Melbourne, June 2011 Question Why should long-range regulation of gene expression be of interest to Clinical Scientists and Pathologists interested

More information

September 8, General Comments:

September 8, General Comments: September 8, 2009 AMP Comments on the draft report from the Agency for Healthcare Research and Quality (AHRQ): AHRQ Draft Report on Quality, Regulation and Clinical Utility of Laboratorydeveloped Tests.

More information

Technology funding opportunities at the National Cancer Institute

Technology funding opportunities at the National Cancer Institute Technology funding opportunities at the National Cancer Institute Through the Cancer Diagnosis Program http://cancerdiagnosis.nci.nih.gov/index.html Avraham Rasooly Ph.D. National Cancer Institute, Cancer

More information

Complex Adaptive Systems Forum: Transformative CAS Initiatives in Biomedicine

Complex Adaptive Systems Forum: Transformative CAS Initiatives in Biomedicine Complex Adaptive Systems Forum: Transformative CAS Initiatives in Biomedicine January 18, 2013 Anna D. Barker, Ph.D. Director, Transformative Healthcare Networks C-Director, Complex Adaptive Systems Initiative

More information

Superior detection of chromosomal aberrations using the latest generation of exon-focused constitutional arrays

Superior detection of chromosomal aberrations using the latest generation of exon-focused constitutional arrays Superior detection of chromosomal aberrations using the latest generation of exon-focused constitutional arrays Investigation of exon-level resolution microarray technology for the identification of important

More information

Crash-course in genomics

Crash-course in genomics Crash-course in genomics Molecular biology : How does the genome code for function? Genetics: How is the genome passed on from parent to child? Genetic variation: How does the genome change when it is

More information

Illumina Diagnostics. Emily Winn-Deen, PhD Vice President, Product Development Diagnostics

Illumina Diagnostics. Emily Winn-Deen, PhD Vice President, Product Development Diagnostics Introduction ti to Illumina Diagnostics Emily Winn-Deen, PhD Vice President, Product Development Diagnostics 2010 Illumina, Inc. All rights reserved. Illumina, illuminadx, Solexa, Making Sense Out of Life,

More information

Dr. Stephen Kingsmore a vision for transforming medicine with rapid genome sequencing

Dr. Stephen Kingsmore a vision for transforming medicine with rapid genome sequencing Dr. Stephen Kingsmore a vision for transforming medicine with rapid genome sequencing Dr. Stephen Kingsmore, MD, DSc, is the President and CEO of the Rady Pediatric Genomics and Systems Medicine Institute.

More information

Pharmacogenetics: A SNPshot of the Future. Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001

Pharmacogenetics: A SNPshot of the Future. Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001 Pharmacogenetics: A SNPshot of the Future Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001 1 I. What is pharmacogenetics? It is the study of how genetic variation affects drug response

More information

University of Athens - Medical School. pmedgr. The Greek Research Infrastructure for Personalized Medicine

University of Athens - Medical School. pmedgr. The Greek Research Infrastructure for Personalized Medicine University of Athens - Medical School pmedgr The Greek Research Infrastructure for Personalized Medicine - George Kollias - Professor of Experimental Physiology, Medical School, University of Athens President

More information

Submission to House of Lords Science and Technology Select Committee Oxford Nanopore Technologies Ltd April 2008

Submission to House of Lords Science and Technology Select Committee Oxford Nanopore Technologies Ltd April 2008 (Previously Oxford NanoLabs) Genomic Medicine Submission to House of Lords Science and Technology Select Committee Oxford Nanopore Technologies Ltd April 2008 Introduction Oxford Nanopore Technologies

More information

REIMAGINING DRUG DEVELOPMENT:

REIMAGINING DRUG DEVELOPMENT: Biology Reconstructed REIMAGINING DRUG DEVELOPMENT: Accurate Disease Modeling To Drive Successful Therapies Julia Kirshner, CEO julia@zpredicta.com 1 SUCCESS RATES OF DRUG DEVELOPMENT ARE LOW, " PARTICULARLY

More information

Solutions will be posted on the web.

Solutions will be posted on the web. MIT Biology Department 7.012: Introductory Biology - Fall 2004 Instructors: Professor Eric Lander, Professor Robert A. Weinberg, Dr. Claudette Gardel NAME TA SEC 7.012 Problem Set 7 FRIDAY December 3,

More information

Chapter 15 The Human Genome Project and Genomics. Chapter 15 Human Heredity by Michael Cummings 2006 Brooks/Cole-Thomson Learning

Chapter 15 The Human Genome Project and Genomics. Chapter 15 Human Heredity by Michael Cummings 2006 Brooks/Cole-Thomson Learning Chapter 15 The Human Genome Project and Genomics Genomics Is the study of all genes in a genome Relies on interconnected databases and software to analyze sequenced genomes and to identify genes Impacts

More information

Oxford Gene Technology The Molecular Genetics Company

Oxford Gene Technology The Molecular Genetics Company Oxford Gene Technology The Molecular Genetics Company CYTOCELL USER GROUP MEETING 2017 Spencer Howell VP European Sales April 2017 1 Welcome everybody Many thanks for your huge interest and fantastic feedback!

More information

Pioneering Clinical Omics

Pioneering Clinical Omics Pioneering Clinical Omics Clinical Genomics Strand NGS An analysis tool for data generated by cutting-edge Next Generation Sequencing(NGS) instruments. Strand NGS enables read alignment and analysis of

More information

14 March, 2016: Introduction to Genomics

14 March, 2016: Introduction to Genomics 14 March, 2016: Introduction to Genomics Genome Genome within Ensembl browser http://www.ensembl.org/homo_sapiens/location/view?db=core;g=ensg00000139618;r=13:3231547432400266 Genome within Ensembl browser

More information

Integrated Course of HUMAN AND MEDICAL GENETICS

Integrated Course of HUMAN AND MEDICAL GENETICS Integrated Course of HUMAN AND MEDICAL GENETICS Scientific Fields: MEDICAL GENETICS (MED/03) APPLIED BIOLOGY (BIO/13) European Credit Transfer and Accumulation System = 7 Coordinator: Prof. BRUNELLA FRANCO,

More information

Integrated Radiology & Pathology Diagnostic Services: The Time is Now at UCLA

Integrated Radiology & Pathology Diagnostic Services: The Time is Now at UCLA Integrated Radiology & Pathology Diagnostic Services: The Time is Now at UCLA Scott W Binder MD Pritzker Professor of Clinical Pathology and Dermatology Senior Vice Chair Director, Pathology Clinical Services

More information

Matthew Tinning Australian Genome Research Facility. July 2012

Matthew Tinning Australian Genome Research Facility. July 2012 Next-Generation Sequencing: an overview of technologies and applications Matthew Tinning Australian Genome Research Facility July 2012 History of Sequencing Where have we been? 1869 Discovery of DNA 1909

More information

THE WHITE HOUSE Office of the Vice President

THE WHITE HOUSE Office of the Vice President FOR IMMEDIATE RELEASE October 17, 2016 THE WHITE HOUSE Office of the Vice President FACT SHEET: Vice President Biden Delivers Cancer Moonshot Report, Announces Public and Private Sector Actions to Advance

More information

Unlocking the Power of the Genome

Unlocking the Power of the Genome Unlocking the Power of the Genome Sam Samad, Chief Financial Officer William Blair Growth Stock Conference, 13 June 2018 2018 Illumina, Inc. All rights reserved. Safe Harbor Statement This presentation

More information

latestdevelopments relevant for the Ag sector André Eggen Agriculture Segment Manager, Europe

latestdevelopments relevant for the Ag sector André Eggen Agriculture Segment Manager, Europe Overviewof Illumina s latestdevelopments relevant for the Ag sector André Eggen Agriculture Segment Manager, Europe Seminar der Studienrichtung Tierwissenschaften, TÜM, July 1, 2009 Overviewof Illumina

More information

TREE CODE PRODUCT BROCHURE

TREE CODE PRODUCT BROCHURE TREE CODE PRODUCT BROCHURE Single Molecule, Real-Time (SMRT) Sequencing technology offers: Long read sequencing ~10 Gb with 20 kb average read lengths for WGS ~20 Gb with 40 kb average read length for

More information

ILLUMINA SEQUENCING SYSTEMS

ILLUMINA SEQUENCING SYSTEMS ILLUMINA SEQUENCING SYSTEMS PROVEN QUALITY. TRUSTED SOLUTIONS. Every day, researchers are using Illumina next-generation sequencing (NGS) systems to better understand human health and disease, as well

More information